Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Papua New Guinea
Papua New Guinea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 2.5% in 2024. ▲ Rising
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Papua New Guinea, 2015–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
Papua New Guinea recorded 2.5% for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in 2024. That is the highest value across all 10 years on record.
Compared with earlier readings it is up 31.6% over ten years.
Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Papua New Guinea peaked at 2.5% in 2022 and was at its lowest, 1.9%, in 2015.
Papua New Guinea ranks 9th of 215 countries on this measure, in the top 10%.
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Papua New Guinea, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.9% | — |
| 2016 | 1.9% | +0.0% |
| 2017 | 1.9% | +0.0% |
| 2018 | 2.0% | +5.3% |
| 2019 | 2.1% | +5.0% |
| 2020 | 2.2% | +4.8% |
| 2021 | 2.4% | +9.1% |
| 2022 | 2.5% | +4.2% |
| 2023 | 2.5% | +0.0% |
| 2024 | 2.5% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2.0% | 1.9% | 2.1% | 5 |
| 2020s | 2.4% | 2.2% | 2.5% | 5 |
Countries ranked near Papua New Guinea
- 6 Guinea 2.8% compare
- 7 Guinea-Bissau 2.7% compare
- 7 Nigeria 2.7% compare
- 10 New Caledonia 2.3% compare
- 11 Chad 2.2% compare
- 12 Equatorial Guinea 2.0% compare
- 12 Saint Helena 2.0% compare
More development goals data for Papua New Guinea
- Red List Index 0.8663 (2025)
- Number of refugees per 100,000 population, by country of origin 5.62 (2025)
- Manufacturing value added per capita 47.38 (2025)
- Number of transboundary breeds 14 (2025)
- Number of transboundary breeds (not extinct) 14 (2025)
- Number of transboundary breeds with unknown risk status 14 (2025)
- Number of local breeds with unknown risk status 9 (2025)
- Number of local breeds (not extinct) 9 (2025)
- Number of local breeds kept in the country 9 (2025)
- Infant deaths 7,969 (2024)
Frequently asked questions
- What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Papua New Guinea?
- Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Papua New Guinea was 2.5% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Papua New Guinea?
- The highest recorded value was 2.5% in 2022.
- What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Papua New Guinea?
- The lowest recorded value was 1.9% in 2015.
- How does Papua New Guinea rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Papua New Guinea ranks 9th out of 215 countries with data for 2024.
- Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Papua New Guinea?
- Over the last ten years it is up 31.6%. The long-run trend across the full record is rising.
- Where does this Papua New Guinea data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).